Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Jakopovic

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Immunotherapy|March 23, 2018
Nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancerSonja Badovinac, Marta Korsic, Kamelija Zarkovic, et al.
Swiss Medical Weekly|August 21, 2007
Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgeryVisnja Majeric Kogler, Zoran Slobodnjak, Miroslav Samarzija, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|July 19, 2019
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patientAna Hecimovic, Andrea Vukic Dugac, Mateja Jankovic Makek, et al.
Journal of Thoracic Disease|August 9, 2016
Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancerSonja Badovinac, Marta Korsic, Davorka Mursic, et al.
Radiology and Oncology|September 22, 2020
Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancerGordana Drpa, Maja Sutic, Jurica Baranasic, et al.
Journal of Water and Health|February 27, 2015
Nosocomial pseudo-outbreak of Mycobacterium gordonae associated with a hospital's water supply contamination: a case series of 135 patientsMarija Zlojtro, Mateja Jankovic, Miroslav Samarzija, et al.
Antioxidants (Basel, Switzerland)|July 16, 2020
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOGFilip Sedlic, Fran Seiwerth, Ana Sepac, et al.
Diagnostic Pathology|September 23, 2016
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in CroatiaLuka Brcic, Marko Jakopovic, Marija Misic, et al.
International Journal of Molecular Sciences|August 26, 2023
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping MutationsUrska Janzic, Walid Shalata, Katarzyna Szymczak, et al.
Pathology|June 25, 2019
Prognostic value of cyclin A2 and B1 expression in lung carcinoidsLuka Brcic, Martin Heidinger, Anita Zenko Sever, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Immunotherapy|March 23, 2018
Nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancerSonja Badovinac, Marta Korsic, Kamelija Zarkovic, et al.
Swiss Medical Weekly|August 21, 2007
Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgeryVisnja Majeric Kogler, Zoran Slobodnjak, Miroslav Samarzija, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|July 19, 2019
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patientAna Hecimovic, Andrea Vukic Dugac, Mateja Jankovic Makek, et al.
Journal of Thoracic Disease|August 9, 2016
Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancerSonja Badovinac, Marta Korsic, Davorka Mursic, et al.
Radiology and Oncology|September 22, 2020
Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancerGordana Drpa, Maja Sutic, Jurica Baranasic, et al.
Journal of Water and Health|February 27, 2015
Nosocomial pseudo-outbreak of Mycobacterium gordonae associated with a hospital's water supply contamination: a case series of 135 patientsMarija Zlojtro, Mateja Jankovic, Miroslav Samarzija, et al.
Antioxidants (Basel, Switzerland)|July 16, 2020
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOGFilip Sedlic, Fran Seiwerth, Ana Sepac, et al.
Diagnostic Pathology|September 23, 2016
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in CroatiaLuka Brcic, Marko Jakopovic, Marija Misic, et al.
International Journal of Molecular Sciences|August 26, 2023
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping MutationsUrska Janzic, Walid Shalata, Katarzyna Szymczak, et al.
Pathology|June 25, 2019
Prognostic value of cyclin A2 and B1 expression in lung carcinoidsLuka Brcic, Martin Heidinger, Anita Zenko Sever, et al.
Pageof 4